About the Authors
- Wiebe M. C. Top
-
Roles Formal analysis, Writing – original draft
Affiliations Department of Internal Medicine, Care Group Treant, Location Bethesda Hoogeveen, Hoogeveen, The Netherlands, Bethesda Diabetes Research Center, Hoogeveen, The Netherlands
- Philippe Lehert
-
Roles Formal analysis
Affiliation Department of Statistics, Faculty of Economics, Facultés Universitaires Catholiques de Mons, Louvain Academy, Mons, Belgium
- Casper G. Schalkwijk
-
Roles Investigation
Affiliation Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands
- Coen D. A. Stehouwer
-
Roles Conceptualization, Writing – review & editing
Affiliation Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands
- Adriaan Kooy
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
* E-mail: a.kooy@treant.nl
Affiliations Department of Internal Medicine, Care Group Treant, Location Bethesda Hoogeveen, Hoogeveen, The Netherlands, Bethesda Diabetes Research Center, Hoogeveen, The Netherlands, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Competing Interests
The authors have read the journal’s policy and have the following competing interests: the HOME trial was supported by grants from Altana, Lifescan, Merck Santé, Merck Sharp & Dohme, and Novo Nordisk awarded to Bethesda General Hospital, Hoogeveen, The Netherlands (1996- 2000), guided by a registered accountant, and raised by AK, initiator and principal investigator of the HOME study. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.